Category: 4569-86-2

On June 30, 2014, Stoichev, Dimitur S.; Razkazov, Nikolai I.; Dobreva, Ekaterina D.; Georgieva, Mihaela G. published a patent.Recommanded Product: 3-Amino-7-(diethylamino)-5-phenylphenazin-5-ium chloride The title of the patent was Electrochemical method for production of copper composite layers on polymer or metal substrates. And the patent contained the following:

An electrochem. method for production of copper composite layers on a flexible polymer or hard metal substrate comprises preparing a substrate by etching, activation and acceleration of a flexible polymer substrate and degreasing and pickling a metal substrate, followed by electroplating at 18-28° and a c.d. of 6 A/dm2 on the cathode and 2.5 A/dm2 on the anode, wherein the electrolyte comprises copper sulfate (70-250), sulfuric acid (40-180), chloride ions (0.04-0.12), poly(ethylene glycol) with a mol. weight of 4000 as a wetting agent (0.03-0.10), polyazo-N,N-diethylsafranine as a leveling agent (0.0035-0.0080), a glitter-forming additive comprising dithiobis(methanesulfonic acid) sodium salt (0.003-0.007) and diamond particles (3-25 g/L) with a particle size from 0.01 to 380 μm pretreated in an aqueous solution of sodium laurylsulfonate (for particles with sizes up to 7 μm) or copper-coated (for particles with sizes of 10-380 μm). The experimental process involved the reaction of 3-Amino-7-(diethylamino)-5-phenylphenazin-5-ium chloride(cas: 4569-86-2).Recommanded Product: 3-Amino-7-(diethylamino)-5-phenylphenazin-5-ium chloride

The Article related to diamond microparticle nanoparticle copper layer electrodeposition polymer metal substrate, Coatings, Inks, and Related Products: Coating Processes and other aspects.Recommanded Product: 3-Amino-7-(diethylamino)-5-phenylphenazin-5-ium chloride

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

On June 30, 2005, Honda, Aki; Suzuki, Koji published a patent.Recommanded Product: 4569-86-2 The title of the patent was Fluorescent assay for measuring environmental allergens using immobilized fluorogenic or chromogenic substrate for protease. And the patent contained the following:

A method and an apparatus for measuring environmental allergens without resort to an anti-allergen antibody, are provided. The method comprises measuring the protease activity of the allergen using a fluorogenic or chromogenic substrate immobilized on a support. Amide conjugates of Leu or Met with cresyl violet, safranine O, methylene violet 3RAX were used to measure aminopeptidase M activity of Mite dermatophagoides farinae and Cedar Pollen-Cj Japanese Cedar. Boc-Val-Leu-Lys-MCA, Leu-MCA, Met-MCA, Boc-Gln-Ala-Arg-MCA, Boc-Val-Leu-Lys-MCA, Bz-Arg-MCA, Glt-Ala-Ala-Phe-MCA, were also used. The experimental process involved the reaction of 3-Amino-7-(diethylamino)-5-phenylphenazin-5-ium chloride(cas: 4569-86-2).Recommanded Product: 4569-86-2

The Article related to environment allergen immobilized fluorogenic chromogenic substrate, Biochemical Methods: Other (Not Covered At Other Subsections) and other aspects.Recommanded Product: 4569-86-2

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

On December 24, 2008, Visintin, Pamela; Jiang, Ping; Korzenski, Michael; King, Mackenzie; Han, Jianwen; Hilgarth, Monica; Liu, Jun; Zhou, Renjie; Minsek, David published a patent.Quality Control of 3-Amino-7-(diethylamino)-5-phenylphenazin-5-ium chloride The title of the patent was Removal composition for wafer reclamation and methods. And the patent contained the following:

A removal composition comprises at least one mineral acid, at least one etchant, at least one oxidizing agent, and optionally water, wherein the removal composition is suitable for removing SiC and/or SiC:N from a microelectronic device structure having the material thereon. The removal composition preferably includes hydrofluoric acid. The composition achieves substantial removal of the material(s) to be removed while not damaging the layers to be retained, for reclaiming, reworking, recycling and/or reuse of said structure. Processes include the monitoring and modifying the compositions The experimental process involved the reaction of 3-Amino-7-(diethylamino)-5-phenylphenazin-5-ium chloride(cas: 4569-86-2).Quality Control of 3-Amino-7-(diethylamino)-5-phenylphenazin-5-ium chloride

The Article related to mineral acid etchant oxidizing agent microelectronic device cleaning, Surface Active Agents and Detergents: Cleaning Compositions and other aspects.Quality Control of 3-Amino-7-(diethylamino)-5-phenylphenazin-5-ium chloride

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

Yang, Ke; Zhang, Xiong; Yang, Fang; Wu, Fengshou; Zhang, Xiulan; Wang, Kai published an article in 2017, the title of the article was DNA photocleavage and binding modes of methylene violet 3RAX and its derivatives: Effect of functional groups.Safety of 3-Amino-7-(diethylamino)-5-phenylphenazin-5-ium chloride And the article contains the following content:

With 4′-amino-N,N-diethylaniline and aniline as starting materials, methylene violet 3RAX 1 and its derivatives 2-5 were synthesized. The 5 compounds were characterized by IR, UV-visible, and 1H NMR spectroscopy and mass spectrometry. The binding mode between the synthesized compounds and DNA were investigated. The results showed that both compounds 1 and 5 bound to DNA by an intercalative mode, while compounds 2-4 interacted with DNA through a mixed binding mode involving groove binding and electrostatic interactions. The photocleavage ability of the 5 compounds to DNA were calculated to be 38, 40, 30, 20, and 13%, resp., when their concentration was adjusted to 400 μM. The singlet oxygen production of compounds measured by the 1,3-diphenylisobenzofuran method was consistent with the trend of DNA photocleavage ability. The DNA studies suggested that the binding mode between methylene violet 3RAX and DNA, the ability of methylene violet 3RAX to generate singlet oxygen, and the DNA photocleavage activity could be adjusted through modification of the amino group on methylene violet 3RAX. The experimental process involved the reaction of 3-Amino-7-(diethylamino)-5-phenylphenazin-5-ium chloride(cas: 4569-86-2).Safety of 3-Amino-7-(diethylamino)-5-phenylphenazin-5-ium chloride

The Article related to dna photocleavage methylene violet derivative preparation binding photodynamic therapy, General Biochemistry: Nucleic Acids and Their Constituents and other aspects.Safety of 3-Amino-7-(diethylamino)-5-phenylphenazin-5-ium chloride

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

On January 31, 2013, Saha, Ishita; Kumar, Gopinatha Suresh published an article.Recommanded Product: 3-Amino-7-(diethylamino)-5-phenylphenazin-5-ium chloride The title of the article was Phenazinium dyes methylene violet 3RAX and indoine blue bind to DNA by intercalation: Evidence from structural and thermodynamic studies. And the article contained the following:

The structural and energetic aspects of the interaction of two important phenazinium dyes methylene violet 3RAX and indoine blue with DNA were studied by spectroscopic and thermochem. techniques. The binding affinity values of both the dyes were of the order of 105 M-1 but methylene violet 3RAX bound to DNA more strongly. Both dyes bound DNA by intercalation but methylene violet 3RAX bound stronger than indoine blue. The DNA binding of both the dyes was exothermic and favored by a small neg. enthalpy and pos. entropy contributions. The effect of ionic strength indicated that electrostatic attraction is an important component of the dye-DNA interaction although the major contribution comes from hydrophobic forces. The temperature dependence of enthalpy changes yielded neg. heat capacity value which was higher for methylene violet 3RAX compared to indoine blue suggesting higher contribution from hydrophobic forces in the interaction of the former. Enthalpy-entropy compensation phenomenon was observed for the binding of both dyes to DNA. The experimental process involved the reaction of 3-Amino-7-(diethylamino)-5-phenylphenazin-5-ium chloride(cas: 4569-86-2).Recommanded Product: 3-Amino-7-(diethylamino)-5-phenylphenazin-5-ium chloride

The Article related to phenazinium dye methylene violet 3rax indoine blue dna intercalation, General Biochemistry: Nucleic Acids and Their Constituents and other aspects.Recommanded Product: 3-Amino-7-(diethylamino)-5-phenylphenazin-5-ium chloride

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

On February 3, 2022, Wang, Xiaomei; Zhu, Lin; Ju, Xiaolei; Wang, Kai; Ye, Changqing; Liang, Zuoqin; Chen, Shuoran published a patent.COA of Formula: C22H23ClN4 The title of the patent was Azaanthracene derivative upconversion system, preparation method therefor and use thereof. And the patent contained the following:

The present invention relates to an azaanthracene derivative upconversion system, a preparation method therefor and use thereof. The azaanthracene derivative free of noble metals and heavy atoms used as a photosensitizer material of TTA-UC can be effectively compounded with a 9,10-diphenylanthracene (DPA) light emitting agent to obtain TTA-UC, and a green-turn-blue upconversion efficiency of up to 9.69% can be obtained. Using the azaanthracene derivative as a light emitting agent material of single photon absorption upconversion, red light of 655 nm excitation can be achieved, a red-turn-yellow single photon absorption upconversion fluorescence color-changing effect of orange-yellow light at about 610 nm can be obtained, and upconversion color changes can be obtained without requiring oxygen removal, thereby enriching the types of light emitting agent materials in the field of single photon absorption upconversion. The azaanthracene derivative has a formula of I, wherein R1 and R2 are selected from NH2 and N(CH2CH3)2, R3 and R4 are selected from H and CH3. The experimental process involved the reaction of 3-Amino-7-(diethylamino)-5-phenylphenazin-5-ium chloride(cas: 4569-86-2).COA of Formula: C22H23ClN4

The Article related to azaanthracene derivative fluorescence upconversion system preparation, Optical, Electron, and Mass Spectroscopy and Other Related Properties: Luminescence and other aspects.COA of Formula: C22H23ClN4

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

On September 24, 1987, Bentz, Bryan L.; Gale, P. Jane published an article.COA of Formula: C22H23ClN4 The title of the article was Characterization of organic dyes aided by hydrogen-deuterium exchange in liquid secondary ion mass spectrometry (liquid SIMS). And the article contained the following:

The SIMS of several cationic dyes dissolved in glycerol and glycerol-d8 were presented. Dyes containing active hydrogens exhibited mass shifts in the spectra obtained from labeled and unlabeled glycerol, allowing inferences about mol. structure to be made. The exchange methodol. is useful in the study of reductive processes occurring in the liquid matrix and in distinguishing isomeric forms of dye compounds The experimental process involved the reaction of 3-Amino-7-(diethylamino)-5-phenylphenazin-5-ium chloride(cas: 4569-86-2).COA of Formula: C22H23ClN4

The Article related to dye hydrogen exchange sims, mass spectra dye hydrogen exchange, Physical Organic Chemistry: Degradation Reactions, Including Mass Spectral Fragmentation and other aspects.COA of Formula: C22H23ClN4

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

On August 19, 2009, Baeyens-Cabrera, Jose Manuel; Buschmann, Helmut H.; Vela Hernandez, Jose Miguel; Zamanillo-Castanedo, Daniel; Nieto-Lopez, Francisco Rafael published a patent.Quality Control of 3-Amino-7-(diethylamino)-5-phenylphenazin-5-ium chloride The title of the patent was Use of compounds binding to the sigma receptor for the treatment of neuropathic pain developing as a consequence of chemotherapy. And the patent contained the following:

The invention discloses the use of compounds binding to the sigma receptor for the treatment or prevention of neuropathic pain resulting from chemotherapy. The experimental process involved the reaction of 3-Amino-7-(diethylamino)-5-phenylphenazin-5-ium chloride(cas: 4569-86-2).Quality Control of 3-Amino-7-(diethylamino)-5-phenylphenazin-5-ium chloride

The Article related to chemotherapy neuropathic pain treatment sigma receptor ligand analgesic, Pharmacology: Effects Of Nervous System- and Behavior-Affecting Drugs and Neuromuscular Agents and other aspects.Quality Control of 3-Amino-7-(diethylamino)-5-phenylphenazin-5-ium chloride

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

On August 27, 2009, Baeyens-Cabrera, Jose Manuel; Buschmann, Helmut H.; Vela-Hernandez, Jose-Miguel; Zamanillo-Castanedo, Daniel; Nieto-Lopez, Francisco Rafael published a patent.Product Details of 4569-86-2 The title of the patent was Use of compounds binding to the sigma receptor for the treatment of neuropathic pain developing as a consequence of chemotherapy. And the patent contained the following:

The present invention refers to the use of compounds binding to the sigma receptor for the treatment or prevention of neuropathic pain resulting from chemotherapy. The invention discloses the use of compounds binding to the sigma receptor for the treatment or prevention of neuropathic pain resulting from chemotherapy. The experimental process involved the reaction of 3-Amino-7-(diethylamino)-5-phenylphenazin-5-ium chloride(cas: 4569-86-2).Product Details of 4569-86-2

The Article related to chemotherapy neuropathic pain treatment sigma receptor ligand analgesic, Pharmacology: Effects Of Nervous System- and Behavior-Affecting Drugs and Neuromuscular Agents and other aspects.Product Details of 4569-86-2

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

On March 8, 2007, Buschmann, Helmut H. published a patent.Application of 4569-86-2 The title of the patent was Use of compounds binding to the sigma receptor for the treatment of diabetes-associated pain. And the patent contained the following:

The invention discloses the use of compounds active on the sigma receptor for the production of a medicament for the treatment of diabetes-associated pain. The experimental process involved the reaction of 3-Amino-7-(diethylamino)-5-phenylphenazin-5-ium chloride(cas: 4569-86-2).Application of 4569-86-2

The Article related to diabetes pain analgesic sigma receptor binding compound, Pharmacology: Effects Of Nervous System- and Behavior-Affecting Drugs and Neuromuscular Agents and other aspects.Application of 4569-86-2

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics